These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17207900)

  • 21. The relative efficacy of antidotes: the IPCS evaluation series. International Programme on Chemical Safety.
    Jacobsen D; Haines JA
    Arch Toxicol Suppl; 1997; 19():305-10. PubMed ID: 9079217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory and ethical considerations for linking clinical and administrative databases.
    Dokholyan RS; Muhlbaier LH; Falletta JM; Jacobs JP; Shahian D; Haan CK; Peterson ED
    Am Heart J; 2009 Jun; 157(6):971-82. PubMed ID: 19464406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials in Israel. Criteria for approval.
    Nir I
    Isr J Med Sci; 1983 May; 19(5):445-8. PubMed ID: 6862851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Woolf AD; Erdman AR; Nelson LS; Caravati EM; Cobaugh DJ; Booze LL; Wax PM; Manoguerra AS; Scharman EJ; Olson KR; Chyka PA; Christianson G; Troutman WG
    Clin Toxicol (Phila); 2007; 45(3):203-33. PubMed ID: 17453872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrity of scientific data: transparency of clinical trial data.
    Moore N; Juillet Y; Bertoye PH;
    Therapie; 2007; 62(3):203-9, 211-6. PubMed ID: 17803887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidote use in the critically ill poisoned patient.
    Betten DP; Vohra RB; Cook MD; Matteucci MJ; Clark RF
    J Intensive Care Med; 2006; 21(5):255-77. PubMed ID: 16946442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Logistics of antidotes in Switzerland].
    Pletscher W; Weiss B
    Ther Umsch; 1992 Feb; 49(2):124-6. PubMed ID: 1553626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European Union centralised procedure for marketing authorisation of oncology drugs: an in-depth review of its efficiency.
    Netzer T
    Eur J Cancer; 2006 Mar; 42(4):446-55. PubMed ID: 16129598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of the concept of antidotes: the contribution of clinical toxicology].
    Fournier E
    Bull Acad Natl Med; 1990; 174(6):703-7; discussion 707-8. PubMed ID: 2271979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of new and established antidotes.
    Bolgiano EB; Barish RA
    Emerg Med Clin North Am; 1994 May; 12(2):317-34. PubMed ID: 8187686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(82):22800-16. PubMed ID: 18567164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of anti-malarial vaccines and need for clinical trials in accordance with international standards in South Africa].
    Doumbo OK; Djimdé AA; Théra MA
    Bull Soc Pathol Exot; 2008 Jun; 101(3):249-53. PubMed ID: 18681219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intermediator relation of the CNS and the improvement in the agents for therapy of drug poisoning].
    Kutsenko SA; Savateev NV
    Farmakol Toksikol; 1989; 52(1):118-23. PubMed ID: 2565249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidotes.
    Perera CS
    Ceylon Med J; 1986 Jun; 31(2):79-82. PubMed ID: 3568202
    [No Abstract]   [Full Text] [Related]  

  • 35. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analysis of studies on piezoelectric surgery in the oral and craniomaxillofacial region with regard to human subject protection and financial conflicts.
    Pitak-Arnnop P; Hemprich A; Sader R; Dhanuthai K; Bertrand JC; Hennig C; Hervé C
    Int J Oral Maxillofac Surg; 2009 Oct; 38(10):1011-3. PubMed ID: 19457643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Process for obtaining informed consent: women's opinions.
    Bento SF; Hardy E; Osis MJ
    Dev World Bioeth; 2008 Dec; 8(3):197-206. PubMed ID: 19046257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
    Jaillon P
    Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.